acut
respiratori
infect
ari
major
caus
death
children
worldwid
primarili
develop
countri
account
million
case
annual
caus
million
death
relat
sever
pneumonia
cap
children
year
age
suscept
cap
older
major
pneumonia
episod
children
year
age
occur
countri
includ
brazil
estim
million
new
case
report
annual
brazil
might
explain
higher
preval
progress
sever
presenc
addit
contribut
risk
factor
therefor
identif
risk
factor
critic
control
cap
creation
prevent
etiolog
cap
divers
complex
howev
continu
identif
major
pathogen
relat
cap
necessari
prevent
improv
context
cap
caus
varieti
pathogen
infecti
agent
includ
virus
bacteria
virus
predomin
among
virus
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
adenoviru
adv
influenza
viru
flua
human
metapneumoviru
hmpv
human
coronaviru
hcov
common
children
howev
frequenc
vari
although
brazil
list
one
countri
highest
estim
new
case
cap
children
studi
investig
viral
incid
brazilian
children
cap
therefor
studi
identifi
rsv
adv
hrv
hmpv
flua
includ
subtyp
well
associ
risk
factor
children
cap
citi
brazilian
region
studi
conduct
dr
odorico
de
amar
mato
children
hospit
capac
includ
fourteen
pediatr
intens
care
unit
bed
six
pediatr
semiintens
care
unit
bed
dr
matto
children
hospit
capac
includ
thirti
pediatr
hospit
bed
academ
public
hospit
serv
sao
lui
citi
brazilian
region
novemb
april
children
cap
enrol
research
studi
popul
compris
patient
rang
age
month
year
month
averag
select
accord
protocol
definit
inclus
criteria
pneumonia
case
defin
use
brazilian
societi
pneumolog
tisiolog
follow
presenc
consolid
dens
fluffi
opac
pulmonari
infiltr
alveolar
interstiti
densiti
pleural
effus
chest
radiographi
b
two
symptom
acut
lower
respiratori
tract
ill
cough
fever
difficulti
breath
tachypnea
breathsmin
children
age
month
breathsmin
children
age
month
andor
wheez
sever
pneumonia
sever
cap
defin
presenc
lower
chest
concav
inabl
eat
drink
vomit
convuls
lethargi
unconsci
sever
malnutrit
less
puls
oximetri
andor
central
cyanosi
addit
inclus
criteria
exclus
criteria
live
attenu
influenza
vaccin
less
day
enrol
b
undergo
otolaryngolog
surgeri
c
presenc
compris
chronic
debilit
diseas
anatom
abnorm
respiratori
tract
cancer
chronic
pulmonari
ill
asthma
immunolog
defect
heart
diseas
clinic
repercuss
hemoglobinopathi
liver
kidney
diseas
mother
studi
approv
research
ethic
committe
ceuma
univers
certif
present
ethic
consider
caae
conduct
complianc
declar
helsinki
written
inform
consent
obtain
particip
behalf
parent
legal
guardian
data
record
use
questionnair
medic
record
includ
age
sex
malnutrit
base
world
health
organ
criterion
type
pregnanc
low
birth
weight
exclus
breastfeed
month
breastfeed
less
month
complet
immun
histori
matern
educ
level
type
deliveri
famili
incom
number
smoker
live
hous
clinic
data
total
season
case
count
calcul
mean
number
case
viral
infect
period
nasopharyng
sampl
collect
enrol
children
use
steril
swab
plast
labor
rio
de
janeiro
brazil
swab
introduc
one
nostril
resist
rotat
collect
sampl
store
ml
nacl
transport
refriger
process
less
hour
centrifug
minut
supernat
store
tracheal
aspir
collect
children
sever
cap
insert
probe
deepli
possibl
directli
collect
bottl
system
broncozamm
tr
model
zammi
instrument
ltd
duqu
de
caxia
brazil
sampl
seal
transport
immedi
laboratori
respiratori
tract
infect
ceuma
univers
process
sampl
dilut
mucolyt
agent
centrifug
minut
supernat
store
viral
nucleic
acid
extract
perform
use
qiaamp
minelut
viru
spin
kit
qiagen
hilden
germani
use
sampl
elut
volum
accord
manufactur
instruct
extract
concentr
puriti
analyz
spectrophotometri
nanolit
thermo
fisher
scientif
complementari
dna
cdna
synthesi
perform
use
cdna
revers
transcript
kit
thermo
fisher
scientif
previous
virus
identifi
quantit
polymeras
chain
reaction
qpcr
use
primer
hydrolysi
probe
rang
nm
ten
microlit
gotaq
probe
qpcr
master
mix
promega
cdna
final
volum
qpcr
assay
perform
use
quantstudio
flex
thermocycl
thermo
fisher
scientif
program
one
cycl
minut
follow
cycl
second
minut
posit
neg
dna
control
use
everi
pcr
assay
avoid
result
primer
probe
use
qpcr
list
tabl
data
analyz
use
graphpad
prism
version
version
softwar
categor
variabl
compar
fisher
exact
test
continu
variabl
compar
student
test
normal
distribut
u
test
without
normal
distribut
statist
signific
defin
p
among
enrol
cap
patient
sever
nonsever
cap
case
occur
children
month
age
children
vaccin
pneumococc
conjug
vaccin
influenza
viru
vaccin
observ
associ
exist
cap
sever
low
children
age
among
patient
sever
manifest
month
old
nonsever
cap
manifest
present
rang
age
p
figur
tabl
show
epidemiolog
data
subject
accord
cap
sever
fact
cap
sever
found
statist
associ
gender
moreov
clear
associ
malnutrit
sever
cap
malnourish
children
sever
cap
compar
nonsever
cap
p
clinic
data
shown
tabl
patient
present
cough
dyspnea
fever
wheez
addit
less
day
symptom
tachypnea
histori
pneumonia
die
almost
half
patient
test
posit
least
one
viru
hrv
show
highest
detect
rate
follow
rsv
adv
hmpv
flua
subtyp
detect
neg
patient
moreov
low
frequenc
observ
subject
respect
compar
sever
cap
patient
hrv
statist
detect
nonsever
cap
children
p
rsv
flua
infect
associ
sever
cap
p
respect
tabl
patient
viral
nucleic
acid
present
coinfect
observ
higher
frequenc
coinfect
children
sever
cap
compar
children
nonsever
cap
p
tabl
observ
major
viral
infect
occur
raini
season
peak
januari
march
figur
moreov
case
rsv
flua
infect
occur
raini
season
contrast
rhinoviru
adv
infect
distribut
throughout
year
higher
peak
rhinoviru
januari
march
accord
world
health
organ
children
year
age
suscept
pneumonia
pneumonia
episod
children
occur
countri
includ
studi
observ
major
cap
case
occur
children
age
less
year
correl
higher
sever
cap
accord
result
barsam
et
investig
main
risk
factor
associ
cap
children
found
children
higher
risk
develop
cap
similarli
li
et
al
investig
incid
cap
chines
children
year
age
report
year
suscept
pneumonia
possibl
first
studi
report
associ
children
year
age
sever
cap
studi
found
interest
gender
associ
male
exhibit
higher
incid
sever
cap
howev
haugen
et
studi
children
nonsever
sever
cap
observ
gender
associ
disagr
suggest
new
studi
higher
number
subject
necessari
resolv
relev
gender
risk
factor
risk
factor
eg
domest
environ
nutrit
crucial
set
cours
infect
howev
etiolog
infect
constitut
fundament
basi
cap
develop
studi
patient
cap
test
posit
least
one
viral
agent
rhinoviru
common
pathogen
found
studi
also
identifi
rhinoviru
among
frequent
virus
identifi
patient
ari
includ
exampl
et
investig
multipl
respiratori
virus
children
cap
salvador
northeastern
brazil
detect
rhinoviru
frequent
howev
despit
high
preval
other
test
liu
et
mention
import
investig
presenc
rhinoviru
sampl
patient
respiratori
infect
report
consid
includ
studi
adv
exhibit
variabl
frequenc
studi
patient
ari
includ
cap
explain
varieti
exist
viral
type
subtyp
adv
subtyp
capabl
infect
studi
low
frequenc
adv
observ
infect
identifi
patient
nonsever
cap
agre
previou
report
also
point
lower
frequenc
adv
infect
nonsever
respiratori
howev
human
adv
respons
larg
outbreak
sever
case
pneumonia
adult
studi
report
children
sever
adenovir
differ
find
might
due
viral
subtyp
given
subtyp
significantli
pathogen
data
show
low
frequenc
rsv
infect
studi
howev
observ
relationship
rsv
infect
sever
cap
interestingli
major
studi
children
sever
cap
report
rsv
common
exampl
jonnalagadda
et
investig
viral
etiolog
children
sever
pneumonia
report
rsv
common
viru
identifi
subject
context
develop
new
vaccin
andor
antivir
rsv
crucial
prevent
treatment
rsv
infect
especi
case
cap
report
patient
posit
flua
sever
pneumonia
sever
previou
studi
also
associ
influenza
viru
cap
sever
mani
show
viru
rapidli
compromis
lung
flua
caus
major
epidem
pandem
around
world
eg
subtyp
respons
high
rate
pneumonia
howev
develop
vaccin
frequent
influenza
subtyp
result
signific
reduct
pneumonia
caus
influenza
might
explain
low
frequenc
found
studi
given
brazil
make
vaccin
avail
children
free
charg
ministri
health
infect
multipl
virus
associ
sever
pneumonia
studi
studi
also
suggest
viral
coinfect
major
contributor
sever
acut
respiratori
exampl
cilla
et
show
greater
need
hospit
patient
infect
singl
viral
infect
howev
studi
suggest
viral
coinfect
result
sever
respiratori
sever
factor
includ
viral
season
pathogen
differ
detect
method
viral
interfer
might
explain
conflict
viral
coinfect
observ
studi
rhinovirusrsv
common
combin
jiang
et
observ
similar
result
show
viral
infect
rhinovirusrsv
codetect
infect
likewis
asner
et
show
among
children
ari
viral
infect
children
rhinovirusrsv
codetect
also
necessari
highlight
environ
directli
influenc
sever
manifest
viru
speci
coinfect
multipl
studi
report
climat
variat
influenc
etiolog
frequenc
cap
context
relev
note
citi
two
distinct
climat
one
raini
season
januari
june
one
dri
season
juli
decemb
studi
observ
season
rhinoviru
infect
morikawa
et
primarili
detect
hrv
type
c
winter
wherea
type
rhinoviru
detect
throughout
year
studi
assess
rhinoviru
type
may
produc
occurr
throughout
year
popul
studi
flua
detect
rain
season
data
agre
data
et
found
predomin
influenza
raini
summer
fall
season
citi
salvador
brazil
hand
caini
et
demonstr
influenza
case
peak
june
septemb
dri
season
countri
southern
hemispher
includ
south
southeast
brazil
regard
season
rsv
bouza
et
analyz
incid
rsv
associ
season
distribut
citi
salvador
brazil
observ
preval
rsv
group
genotyp
dri
season
hand
higher
incid
rsv
group
b
genotyp
raini
season
result
agre
understand
season
associ
pathogen
fundament
develop
season
strategi
prevent
current
avail
antivir
medic
treatment
cap
vaccin
avail
influenza
come
futur
research
reach
potenti
challeng
includ
patient
evalu
nutrit
intervent
popul
educ
hygien
habit
make
molecular
character
viru
strain
besid
identifi
bacteri
etiolog
anoth
challeng
includ
nonpneumonia
group
may
help
better
comprehend
respiratori
infect
children
studi
shown
rhinoviru
adv
detect
usual
even
among
children
without
may
virus
caus
minim
mild
diseas
depend
subtyp
combin
bacteri
viral
coinfect
may
result
cap
sever
cap
hypothesi
follow
observ
detect
virus
nasopharynx
children
absenc
clinic
sign
first
studi
conduct
citi
brazilian
region
identifi
virus
children
cap
conclus
inform
lead
refin
old
develop
new
strategi
prevent
treatment
viral
respiratori
infect
author
declar
conflict
interest
studi
support
grant
da
brazil
